Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 20 studies | 65% ± 19% | |
endothelial cell | 15 studies | 31% ± 17% | |
oligodendrocyte precursor cell | 13 studies | 48% ± 15% | |
GABAergic neuron | 11 studies | 56% ± 21% | |
glutamatergic neuron | 11 studies | 54% ± 24% | |
interneuron | 7 studies | 59% ± 20% | |
smooth muscle cell | 6 studies | 23% ± 4% | |
neuron | 5 studies | 41% ± 17% | |
pericyte | 5 studies | 32% ± 17% | |
amacrine cell | 5 studies | 47% ± 27% | |
cardiac muscle cell | 4 studies | 23% ± 3% | |
Mueller cell | 4 studies | 39% ± 11% | |
retina horizontal cell | 4 studies | 25% ± 7% | |
brush cell | 4 studies | 27% ± 10% | |
fibroblast | 4 studies | 22% ± 8% | |
oligodendrocyte | 4 studies | 27% ± 12% | |
GABAergic interneuron | 3 studies | 56% ± 11% | |
epithelial cell | 3 studies | 35% ± 14% | |
granule cell | 3 studies | 45% ± 12% | |
GABAergic amacrine cell | 3 studies | 53% ± 9% | |
glycinergic amacrine cell | 3 studies | 61% ± 16% | |
ependymal cell | 3 studies | 57% ± 13% | |
endothelial cell of lymphatic vessel | 3 studies | 22% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 5582.84 | 2642 / 2642 | 100% | 265.81 | 704 / 705 |
prostate | 97% | 1282.08 | 238 / 245 | 96% | 7.94 | 482 / 502 |
adrenal gland | 95% | 812.15 | 244 / 258 | 92% | 12.33 | 211 / 230 |
ovary | 99% | 1170.40 | 179 / 180 | 86% | 8.40 | 369 / 430 |
kidney | 81% | 629.98 | 72 / 89 | 92% | 9.71 | 828 / 901 |
thymus | 98% | 1084.05 | 641 / 653 | 73% | 6.18 | 442 / 605 |
breast | 87% | 726.49 | 400 / 459 | 67% | 5.05 | 754 / 1118 |
uterus | 98% | 1439.71 | 167 / 170 | 36% | 3.95 | 165 / 459 |
skin | 44% | 363.50 | 805 / 1809 | 87% | 9.68 | 411 / 472 |
lung | 89% | 908.06 | 516 / 578 | 36% | 2.37 | 413 / 1155 |
bladder | 86% | 1222.29 | 18 / 21 | 34% | 2.88 | 172 / 504 |
intestine | 83% | 1616.70 | 802 / 966 | 25% | 1.43 | 130 / 527 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.47 | 1 / 1 |
blood vessel | 99% | 1439.17 | 1319 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 20% | 127.89 | 66 / 328 | 78% | 6.19 | 139 / 178 |
heart | 93% | 1052.31 | 804 / 861 | 0% | 0 | 0 / 0 |
adipose | 89% | 764.54 | 1068 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 65% | 1313.27 | 940 / 1445 | 17% | 0.98 | 31 / 183 |
stomach | 54% | 726.67 | 195 / 359 | 27% | 1.79 | 78 / 286 |
spleen | 65% | 445.46 | 156 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 63% | 4.10 | 50 / 80 |
tonsil | 0% | 0 | 0 / 0 | 18% | 0.89 | 8 / 45 |
liver | 4% | 23.37 | 9 / 226 | 13% | 0.79 | 51 / 406 |
lymph node | 0% | 0 | 0 / 0 | 10% | 1.70 | 3 / 29 |
muscle | 1% | 8.18 | 11 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1900181 | Biological process | negative regulation of protein localization to nucleus |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0021766 | Biological process | hippocampus development |
GO_0034504 | Biological process | protein localization to nucleus |
GO_0021860 | Biological process | pyramidal neuron development |
GO_0000226 | Biological process | microtubule cytoskeleton organization |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005737 | Cellular component | cytoplasm |
GO_0008017 | Molecular function | microtubule binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | DCLK2 |
Protein name | non-specific serine/threonine protein kinase (EC 2.7.11.1) Serine/threonine-protein kinase DCLK2 (EC 2.7.11.1) (CaMK-like CREB regulatory kinase 2) (CL2) (CLICK-II) (CLICK2) (Doublecortin domain-containing protein 3B) (Doublecortin-like and CAM kinase-like 2) (Doublecortin-like kinase 2) Doublecortin like kinase 2 |
Synonyms | hCG_18043 DCK2 DCAMKL2 DCDC3B |
Description | FUNCTION: Protein kinase with a significantly reduced C(a2+)/CAM affinity and dependence compared to other members of the CaMK family. May play a role in the down-regulation of CRE-dependent gene activation probably by phosphorylation of the CREB coactivator CRTC2/TORC2 and the resulting retention of TORC2 in the cytoplasm (By similarity). . |
Accessions | A0A0U1RR70 ENST00000635524.1 Q8N568 G5E9L9 ENST00000296550.12 [Q8N568-1] ENST00000506325.5 [Q8N568-2] A0A0U1RRD0 ENST00000411937.6 ENST00000302176.8 [Q8N568-3] ENST00000634233.1 |